dc.creatorRabelo Socca E.A.
dc.creatorLuiz-Ferreira A.
dc.creatorDe Faria F.M.
dc.creatorDe Almeida A.C.
dc.creatorDunder R.J.
dc.creatorManzo L.P.
dc.creatorSouza Brito A.R.M.
dc.date2014
dc.date2015-06-25T18:02:19Z
dc.date2015-11-26T15:04:21Z
dc.date2015-06-25T18:02:19Z
dc.date2015-11-26T15:04:21Z
dc.date.accessioned2018-03-28T22:15:10Z
dc.date.available2018-03-28T22:15:10Z
dc.identifier
dc.identifierChemico-biological Interactions. , v. 209, n. 1, p. 48 - 55, 2014.
dc.identifier92797
dc.identifier10.1016/j.cbi.2013.11.019
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84891681369&partnerID=40&md5=057a669330630063fcf0a363be1b688d
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/87787
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/87787
dc.identifier2-s2.0-84891681369
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1256825
dc.descriptionIsatin, an indole alkaloid has been shown to have anti-microbial, anti-tumor and anti-inflammatory effects. Due to its findings, we evaluated whether this alkaloid would have any effect on TNBS-induced colitis. Animals (male Unib:WH rats, aged 8 weeks old) were induced colitis through a rectal administration of 2,4,6-trinitrobenzene sulphonic acid using a catheter inserted 8 cm into the rectum of the animals. The rats were divided into two major groups: non-colitic and colitic. The colitic group was sub-divided into 6 groups (10 animals per group): colitic non-treated, Isatin 3; 6; 12.5; 18.75 and 25 mg/kg. Our main results showed that the oral treatment with Isatin 6 and 25 mg/kg were capable of avoiding the increase in TNF-α, COX-2 and PGE 2 levels when compared to the colitic non-treated group. Interestingly, the same doses (6 and 25 mg/kg) were also capable of preventing the decrease in IL-10 levels comparing with the colitic non-treated group. The levels of MPO, (an indirect indicator of neutrophil presence), were also maintained lower than those of the colitic non-treated group. Isatin also prevented the decrease of SOD activity and increase of GSH-Px and GSH-Rd activity as well as the depletion of GSH levels. In conclusion, both pre-treatments (6 and 25 mg/kg) were capable of protecting the gut mucosa against the injury caused by TNBS, through the combination of antioxidant and anti-inflammatory properties, which, together, showed a protective activity of the indole alkaloid Isatin. © 2013 Elsevier Ireland Ltd. All rights reserved.
dc.description209
dc.description1
dc.description48
dc.description55
dc.descriptionMonteleone, G., Caruso, R., Pallone, F., Targets for new immunomodulation strategies in inflammatory bowel disease (2013) Autoimmun. Rev., 13 (1), pp. 11-14
dc.descriptionKo, J.K., Auyeung, K.K., Inflammatory bowel disease: Etiology, pathogenesis and current therapy (2013) Curr. Pharm. Des., , [Epub ahead of print]
dc.descriptionCartes, M.J., Lobo, A.J., Travis SP on behalf of the IBD Section of the British Society of Gastroenterology (2004) Guidelines for the Management of Inflammatory Bowel Disease in Adults, Gut, 53 (SUPPL. 5), pp. V1-V16
dc.descriptionTravis, S.P., Stange, E.F., Lemann, M., Oresland, T., Chowers, Y., Forbes, A., D'Haens, G., Colitis, O., European evidence based consensus on the diagnosis and management of Crohn's disease: Current management (2006) Gut, 55 (SUPPL. 1), pp. 16-i35
dc.descriptionBernstein, C.N., Fried, M., Krabshuis, J.H., Cohen, H., Eliakim, R., Fedail, S., Gearry, R., Watermeyer, G., World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010 (2010) Inflamm. Bowel Dis., 16, pp. 112-124
dc.descriptionPrantera, C., Marconi, S., Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity (2013) Ther. Adv. Gastroenterol., 6, pp. 137-156
dc.descriptionSergent, T., Piront, N., Meurice, J., Toussaint, O., Schneider, Y.J., Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium (2010) Chem. Biol. Interact., 188, pp. 659-667
dc.descriptionCandido-Bacani Pde, M., Mori, M.P., Calvo, T.R., Vilegas, W., Varanda, E.A., Colus, I.M., In vitro assessment of the cytotoxic, apoptotic, and mutagenic potentials of isatin (2013) J. Toxicol. Environ. Health A, 76, pp. 354-362
dc.descriptionPakravan, P., Kashanian, S., Khodaei, M.M., Harding, F.J., Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity (2013) Pharmacol. Rep., 65, pp. 313-335
dc.descriptionSilva, B.V., Isatin, a versatile molecule: Studies in Brazil (2013) J. Bras. Chem. Soc., 24, pp. 707-720
dc.descriptionKandasamy, R., Park, S.J., Boyapalle, S., Mohapatra, S., Hellermann, G.R., Lockey, R.F., Mohapatra, S.S., Isatin down-regulates expression of atrial natriuretic peptide receptor A and inhibits airway inflammation in a mouse model of allergic asthma (2010) Int. Immunopharmacol., 10, pp. 218-225
dc.descriptionMatheus, M.E., Violante, F.D.A., Garden, S.J., Pinto, A.C., Fernandes, P.D., Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line (2007) European Journal of Pharmacology, 556 (1-3), pp. 200-206. , DOI 10.1016/j.ejphar.2006.10.057, PII S001429990601243X
dc.descriptionMorris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon (1989) Gastroenterology, 96 (3), pp. 795-803
dc.descriptionBell, C.J., Gall, D.G., Wallace, J.L., Disruption of colonic electrolyte transport in experimental colitis (1995) Am. J. Physiol., 268, pp. 622-G630
dc.descriptionWinterbourn, C.C., Hawkins, R.E., Brian, M., Carrell, R.W., The estimation of red cell superoxide dismutase activity (1975) J. Lab. Clin. Med., 85, pp. 337-341
dc.descriptionAnderson, M.E., Determination of glutathione and glutathione disulfide in biological samples (1985) Methods in Enzymology, VOL. 113, pp. 548-555
dc.descriptionYoshikawa, T., Naito, Y., Kishi, A., Tomii, T., Kaneko, T., Iinuma, S., Ichikawa, H., Kondo, M., Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats (1993) Gut, 34 (6), pp. 732-737
dc.descriptionCarlberg, I., Mannervik, B., Reduction of 2,4,6-trinitrobenzenesulfonate by glutathione reductase and the effect of NADP+ on the electron transfer (1986) Journal of Biological Chemistry, 261 (4), pp. 1629-1635
dc.descriptionKrawisz, J.E., Sharon, P., Stenson, W.F., Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models (1984) Gastroenterology, 87 (6), pp. 1344-1350
dc.descriptionRomero-Calvo, I., Ocon, B., Martinez-Moya, P., Suarez, M.D., Zarzuelo, A., Martinez-Augustin, O., De Medina, F.S., Reversible Ponceau staining as a loading control alternative to actin in Western blots (2010) Anal. Biochem., 401, pp. 318-320
dc.descriptionTe Velde, A.A., Verstege, M.I., Hommes, D.W., Critical appraisal of the current practice in murine TNBS-induced colitis (2006) Inflammatory Bowel Diseases, 12 (10), pp. 995-999. , DOI 10.1097/01.mib.0000227817.54969.5e, PII 0005472520061000000009
dc.descriptionPremanathan, M., Radhakrishnan, S., Kulangiappar, K., Singaravelu, G., Thirumalaiarasu, V., Sivakumar, T., Kathiresan, K., Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl (2012) Indian J. Med. Res., 136, pp. 822-826
dc.descriptionPaiotti, A.P., Miszputen, S.J., Oshima, C.T., De Oliveira Costa, H., Ribeiro, D.A., Franco, M., Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats (2009) J. Mol. Histol., 40, pp. 317-324
dc.descriptionOz, H.S., Zhong, J., De Villiers, W.J., Osteopontin ablation attenuates progression of colitis in TNBS model (2012) Dig. Dis. Sci., 57, pp. 1554-1561
dc.descriptionOz, H.S., Zhong, J., De Villiers, W.J., Pegylated arginine deiminase downregulates colitis in murine models (2012) Mediators Inflamm., 2012, p. 813892
dc.descriptionMartinon, F., Signaling by ROS drives inflammasome activation (2010) Eur. J. Immunol., 40, pp. 616-619
dc.descriptionBouzid, D., Gargouri, B., Mansour, R.B., Amouri, A., Tahri, N., Lassoued, S., Masmoudi, H., Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients (2013) Saudi J. Gastroenterol., 19, pp. 131-135
dc.descriptionBiasi, F., Leonarduzzi, G., Oteiza, P.I., Poli, G., Inflammatory bowel disease: Mechanisms, redox considerations, and therapeutic targets (2013) Antioxid. Redox Signal., 19 (14), pp. 1711-1747
dc.descriptionValko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease (2007) International Journal of Biochemistry and Cell Biology, 39 (1), pp. 44-84. , DOI 10.1016/j.biocel.2006.07.001, PII S1357272506002196
dc.descriptionKannan, N., Guruvayoorappan, C., Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators (2013) Int. Immunopharmacol., 16, pp. 57-66
dc.descriptionRoessner, A., Kuester, D., Malfertheiner, P., Schneider-Stock, R., Oxidative stress in ulcerative colitis-associated carcinogenesis (2008) Pathol. Res. Pract., 204, pp. 511-524
dc.descriptionQuintana-Cabrera, R., Bolanos, J.P., Glutathione and gamma-glutamylcysteine in hydrogen peroxide detoxification (2013) Methods Enzymol., 527, pp. 129-144
dc.descriptionOz, H.S., Chen, T.S., Nagasawa, H., Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model (2007) Translational Research, 150 (2), pp. 122-129. , DOI 10.1016/j.trsl.2006.12.010, PII S1931524407000436
dc.descriptionMiralles-Barrachina, O., Savoye, G., Belmonte-Zalar, L., Hochain, P., Ducrotte, P., Hecketsweiler, B., Lerebours, E., Dechelotte, P., Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: The role of malnutrition (1999) Clinical Nutrition, 18 (5), pp. 313-317. , DOI 10.1016/S0261-5614(98)80030-7
dc.descriptionYou, Y., Fu, J.J., Meng, J., Huang, G.D., Liu, Y.H., Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity (2009) Dig. Dis. Sci., 54, pp. 1643-1650
dc.descriptionKim, S.J., Jung, H.J., Hyun, D.H., Park, E.H., Kim, Y.M., Lim, C.J., Glutathione reductase plays an anti-apoptotic role against oxidative stress in human hepatoma cells (2010) Biochimie, 92, pp. 927-932
dc.descriptionDe Faria, F.M., Luiz-Ferreira, A., Socca, E.A., De Almeida, A.C., Dunder, R.J., Manzo, L.P., Da Silva, M.A., Souza Brito, A.R., Effects of Rhizophora mangle on experimental colitis induced by TNBS in rats (2012) Evid Based Complement Alternat. Med., 2012, p. 753971
dc.descriptionDrew, J.E., Arthur, J.R., Farquharson, A.J., Russell, W.R., Morrice, P.C., Duthie, G.G., Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon (2005) Biochemical Pharmacology, 70 (6), pp. 888-893. , DOI 10.1016/j.bcp.2005.06.011, PII S0006295205004016
dc.descriptionCereser, C., Boget, S., Parvaz, P., Revol, A., Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death (2001) Toxicology, 163 (2-3), pp. 153-162. , DOI 10.1016/S0300-483X(01)00401-2, PII S0300483X01004012
dc.descriptionBorrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Izzo, A.A., Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (2013) Biochem. Pharmacol., 85, pp. 1306-1316
dc.descriptionMoussa, L., Bezirard, V., Salvador-Cartier, C., Bacquie, V., Lencina, C., Leveque, M., Braniste, V., Houdeau, E., A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease (2012) PLoS One, 7, p. 49547
dc.descriptionNishitani, Y., Zhang, L., Yoshida, M., Azuma, T., Kanazawa, K., Hashimoto, T., Mizuno, M., Intestinal anti-inflammatory activity of lentinan: Influence on IL-8 and TNFR1 expression in intestinal epithelial cells (2013) PLoS One, 8, p. 62441
dc.descriptionDe Almeida, A.B., Sanchez-Hidalgo, M., Martin, A.R., Luiz-Ferreira, A., Trigo, J.R., Vilegas, W., Dos Santos, L.C., De La Lastra, C.A., Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model (2013) J. Ethnopharmacol., 146, pp. 300-310
dc.descriptionCho, E.J., Shin, J.S., Noh, Y.S., Cho, Y.W., Hong, S.J., Park, J.H., Lee, J.Y., Lee, K.T., Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis (2011) J. Ethnopharmacol., 136, pp. 428-435
dc.descriptionDa Silva, M.S., Sanchez-Fidalgo, S., Talero, E., Cardeno, A., Da Silva, M.A., Villegas, W., Souza Brito, A.R., De La Lastra, C.A., Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model (2010) J. Ethnopharmacol., 128, pp. 467-475
dc.descriptionWang, Q., Guo, X.-L., Wells-Byrum, D., Noel, G., Pritts, T.A., Ogle, C.K., Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured caco-2 cells (2008) Shock, 29 (4), pp. 531-537. , DOI 10.1097/SHK.0b013e318150737f, PII 0002438220080400000017
dc.descriptionMa, T.Y., Iwamoto, G.K., Hoa, N.T., Akotia, V., Pedram, A., Boivin, M.A., Said, H.M., TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation (2004) Am. J. Physiol. Gastrointest. Liver Physiol., 286, pp. 367-G376
dc.descriptionAl-Sadi, R.M., Ma, T.Y., IL-1β causes an increase in intestinal epithelial tight junction permeability (2007) Journal of Immunology, 178 (7), pp. 4641-4649
dc.descriptionSchaffer, M., Bongartz, M., Hoffmann, W., Viebahn, R., Regulation of nitric oxide synthesis in wounds by IFN-γ depends on TNF-α (2006) Journal of Investigative Surgery, 19 (6), pp. 371-379. , DOI 10.1080/08941930600985710, PII L152X74417T3U100
dc.descriptionPark, Y.S., COX-2 inhibitors in inflammatory bowel disease: Friends or foes? (2007) Korean J. Gastroenterol., 50, pp. 350-355
dc.descriptionRizzo, M.T., Cyclooxygenase-2 in oncogenesis (2011) Clin. Chim. Acta, 412, pp. 671-687
dc.descriptionNagib, M.M., Tadros, M.G., Elsayed, M.I., Khalifa, A.E., Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats (2013) Toxicol. Appl. Pharmacol., 271, pp. 106-113
dc.descriptionOtani, T., Yamaguchi, K., Scherl, E., Du, B., Tai, H.H., Greifer, M., Petrovic, L., Dannenberg, A.J., Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: Evidence for involvement of TNF-alpha (2006) Am. J. Physiol. Gastrointest. Liver Physiol., 290, pp. 361-G368
dc.descriptionSheibanie, A.F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., Ganea, D., The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis (2007) Journal of Immunology, 178 (12), pp. 8138-8147
dc.descriptionWang, D., Dubois, R.N., The role of COX-2 in intestinal inflammation and colorectal cancer (2010) Oncogene, 29, pp. 781-788
dc.descriptionJiang, G.-L., Nieves, A., Wha, B.I., Old, D.W., Dinh, D.T., Wheeler, L., The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration (2007) Journal of Pharmacology and Experimental Therapeutics, 320 (1), pp. 22-28. , http://jpet.aspetjournals.org/cgi/reprint/320/1/22, DOI 10.1124/jpet.106.111146
dc.descriptionMacdonald, T.T., Vossenkaemper, A., Fantini, M., Monteleone, G., Reprogramming the immune system in IBD (2012) Dig. Dis., 30, pp. 392-395
dc.descriptionBrant, S.R., Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery (2013) Clin. Gastroenterol. Hepatol., 11, pp. 22-26
dc.descriptionLindsay, J., Van Montfrans, C., Brennan, F., Van Deventer, S., Drillenburg, P., Hodgson, H., Te Velde, A., Sol Rodriguez Pena, M., IL-10 gene therapy prevents TNBS-included colitis (2002) Gene Therapy, 9 (24), pp. 1715-1721. , DOI 10.1038/sj.gt.3301841
dc.descriptionZhou, Y., Wang, H., Liang, L., Zhao, W.C., Chen, Y., Deng, H.Z., Total alkaloids of Sophora alopecuroides increases the expression of CD4+ CD25+ Tregs and IL-10 in rats with experimental colitis (2010) Am. J. Chin. Med., 38, pp. 265-277
dc.languageen
dc.publisher
dc.relationChemico-Biological Interactions
dc.rightsfechado
dc.sourceScopus
dc.titleInhibition Of Tumor Necrosis Factor-alpha And Cyclooxigenase-2 By Isatin: A Molecular Mechanism Of Protection Against Tnbs-induced Colitis In Rats
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución